Imperial Brands PLC, a FTSE 100 tobacco and nicotine products company headquartered in the UK, engages in EU lobbying primarily through its Brussels office. Registered in the EU Transparency Register since 2011 (ID: 62460931291-40), it focuses on influencing tobacco regulation, excise policies, and public health legislation. Key targets include the Tobacco Products Directive (2014/40/EU), excise duty directives (2011/64/EC, 2008/118/EC), and anti-illicit trade measures. The firm advocates for “science-based” regulations, particularly seeking differentiated rules for e-cigarettes versus traditional tobacco2. Notably, in 2019, Imperial funded a European Citizens’ Initiative (“Let’s demand smarter vaping regulation”) via a €10,000 donation and PR support, aiming to revoke Article 20 of the Tobacco Products Directive. It collaborates with industry groups like Tobacco Europe (where it is a full member alongside BAT and JTI) and national tobacco associations across Europe. Recent scrutiny by the EU Ombudsman (2023) highlighted transparency concerns in the Commission’s interactions with tobacco lobbyists, including Imperial